The Future of Cord Blood

Photo of an unborn baby with umbilical cord

Once thought to be a useless byproduct, umbilical cord blood now treats more than 80 diseases, and it may soon be used to treat more.

Biosimilars: From Concept to Reality

BSTQ Fall 2018 biosimilars thumbnail

Approvals in 2018 brought the total number of U.S. Food and Drug Administration-licensed biosimilars well into the double digits — and more are in the pipeline.

Update on Metastatic Cancer

cancer cells

Thousands of studies are investigating how and why cancer metastasizes and how to more effectively treat it.